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Introduction
Trigeminal neuralgia (TN) can be managed by medical and
surgical treatment. Half of the patients are cured by drugs
(particularly carbamazepine) without side effects, 25% are
cured but have intolerable side effects and 25% are not
cured [1]. Then, half of the patients require surgical treat-
ment. When drugs become ineffective or not tolerated, the
question of which intervention (percutaneous or open) is
appropriate becomes an important issue. Among modern
operations, three are percutaneous (trigeminal percutaneous
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Abstract The aim of this study was
to define criteria for the selection of
patients for percutaneous or open
operations for the cure of drug-resis-
tant trigeminal neuralgia (TN).
Trigeminal percutaneous radiofre-
quency thermorhizotomy (TPRT) has
an established place because of its
safety in elderly patients, while
microvascular decompression
(MVD) has appeal in younger
patients because of its non-destruc-
tive nature and because it attacks
what is believed to be the primary
etiology of tic douloureux.
Nevertheless, MVD is a successful
operation only when true neurovas-
cular conflict (NVC) is ascertained,
rather than a simple arterial loop and
neurovascular contact. Probably,
many immediate failures and early
relapses are the consequence of the
inadequate patient selection for
MVD on the presumption that this
operation is in any case the ideal
cure. The inadequate selection can be
explained by the difficult preopera-
tive diagnosis of NVC in the past.
Indeed, angiography and computed
tomography showed the neurovascu-
lar contact but not the size of com-
pression. Fortunately, today magnetic
resonance imaging is a reliable
instrument to ascertain NVC. So, the
diatribe between the supporters of
percutaneous techniques and MVD
can be concluded with the following:
(1) percutaneous techniques are indi-
cated for patients without demon-
strated NVC (including patients with
TN in multiple sclerosis) and in
those with NVC if MVD is con-
traindicated by ill-health or refused
by the informed patient; and (2)
MVD is indicated for patients with
ascertained NVC who are in good
health and who, informed of the sur-
gical risk, favor this operation desir-
ing no sensory deficit.
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radiofrequency thermorhizotomy (TPRT) [2], retrogasserian
glycerol injection (RGI) [3] and percutaneous compression
of the trigeminal ganglion (PCTG) [4]) and two are open
(partial sensory rhizotomy (PSR) [5] and microvascular
decompression (MVD) [6]).
The debate between the supporters of open techniques
(particularly MVD) [7–14] and of percutaneous techniques
(particularly TPRT) [15–24] has lasted many years. The for-
mer sustain that MVD is the “definitive physiologic rather
than symptomatic operative treatment of patients with
trigeminal neuralgia” [25] and the only non-destructive sur-
gical treatment which produces pain control without sensory
impairment nor postoperative dysesthesia [26, 27]. The latter
point out that TPRT avoids the risks of craniectomy, it is
repeated easily if tic pain recurs, morbidity is minimal and
there is essentially no risk of mortality. Burchiel et al. [28]
sustained that MVD should be considered because it attacks
what is believed to be the primary etiology of tic douloureux,
the trigeminal nerve is preserved, postoperative pain relief
does not depend upon the production of sensory deficit and it
may have a greater potential to produce long-lasting pain
relief. Möbius et al. [29] affirmed that MVD should espe-
cially be recommended for patients in whom all other forms
of therapy including TPRT have failed. Walchenbach et al.
[30] stated that as neither TPRT nor MVD is an unequivo-
cally more effective treatment, the less invasive procedure
should be preferred. Morley [31] put the question if “it is jus-
tified to place the patient at a 1% risk of death and a 10% risk
of significant, sometimes grave morbidity for the treatment
of a condition that is never fatal when other procedures are
available that are effective and carry virtually no risk of death
or neurologic morbidity other than planned sensory impair-
ment”. Soyka [32] affirmed that the principle of MVD is
either an interruption of the pain-conducting fibers or a non-
specific manipulation at the gasserian ganglion or the senso-
ry root with the result of an interruption of abnormal ephaps-
es and short-circuits and that the operation should not be con-
sidered to be a specific and causal therapeutic approach as
well as the therapy of first choice for all cases. Taha and Tew
[33, 34] affirmed that TPRT is the procedure of choice for
most patients undergoing first surgical treatment and that
MVD is recommended for healthy patients who desire no
sensory deficit. On the contrary, Kunze and Steiner [9]
affirmed that in every case of typical TN there is an indica-
tion for MVD, provided that pharmacotherapy has proved
ineffective and anesthesia carries no increased risk due to old
age or ill-health. For patients under 65 years, Broggi et al.
[35] proposed PCTG or, if neuroradiological evidence of
neurovascular conflict (NVC) is given, MVD; for patients
older than 65 years, these authors proposed TPRT.
Considering these different opinions and the lack of firm
evidence for choosing the surgical treatment, the aim of this
study was to define criteria for the selection of patients under-
going percutaneous or open operations through an up to date
review of the literature on the outcome of TPRT (the more
classic percutaneous surgical treatment of TN) and MVD.
Materials and methods
Out of all published reports of patients treated by TPRT or MVD,
papers with an average follow-up of 3 years or longer were select-
ed. According to this criterium, 18 studies including 7473 TN
patients treated by TPRT (Table 1) with a follow-up from 3 to 9.3
years (average 5.8 years) and 17 studies including 3611 patients
treated by MVD (Table 2) with a follow-up from 3 to 8.5 years
(average 5 years) were considered. The results are indicated as the
average of the values of the different papers.
Results
Immediate pain relief was achieved in 92.5% of patients
treated with TPRT and 90.4% of patients undergoing MVD.
Relapses of pain were observed in 24.4% of TPRT cases and
in 21% of MVD cases. The predictable postoperative pain
relief examined with the Kaplan-Meier plot [36] showed a
half-life of 3 years [37], 5 years [38] or more than 5 years
[39] for TPRT and of 10 years [40] for MVD. Facial senso-
ry deficit was a common and wanted finding in TPRT cases
and an unwanted remark in 8.9% of MVD cases.
Dysesthesia was reported by 15.6% of patients treated
by TPRT: it was mild (non-disturbing and non-requiring
treatment) in 7.9% of cases, moderate (disturbing but con-
trolled by drugs) in 5.9% and severe (disturbing and not
controlled by drugs) or anesthesia dolorosa in 1.8%. In
MVD-treated patients, dysesthesia was not quoted among
the complications.
Motor deficits figured in 7.3% of patients treated with
TPRT. Damage to cranial nerves other than V figured in
0.4% of TPRT cases (particularly, IV and VI with transient
diplopia) and in 7.4% of MVD cases (particularly, VII and
VIII with bradyacusia or deafness).
Fritz et al. [41] observed that out of 21 patients examined
audiometrically before and after MVD, five (23.8%) had
postoperative hearing impairment. Fuse and Miller [42]
observed a delayed and progressive hearing loss after MVD,
which they interpreted to be the result of reactive scar tissue
and atrophy of the auditory nerve. Vestibular nerve injuries
were also described [43] and, moreover, peduncular halluci-
nosis [44, 45].
Other possible major neurological complications after
MVD are: cerebellar hemorrhage, edema or infarction, arter-
ial air embolism, acute mental status change, status epilepti-





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































subarachnoid hemorrhage, aseptic or bacterial meningitis,
cerebrospinal fluid leak (CSF) leak, hydrocephalus and
infarction of the brain stem. Finally, operative death occurred
in 0.03% and 0.6% of patients undergoing TPRT and MVD,
respectively.
Considering the outcome of TPRT and MVD in multiple
sclerosis-related TN (MS-TN), Siegfried [46] affirmed that
pain can be successfully eliminated by operation. Brisman
[47] found that the probability of recurrence showed no sig-
nificant differences in 16 patients with MS-TN compared
with 219 patients without MS. Only Broggi and Franzini
[48] observed a high recurrence rate in the MS-TN group
(40% at 1–4 years of follow-up). On the other hand, Resnick
et al. [49] affirmed that MVD fails to provide adequate or
reliable pain relief in MS-TN. 
Discussion
TPRT, the selective thermolesion of the trigeminal ganglion
and root, has the faculty to control preoperatively by elec-
trostimulation the trigeminal division(s) involved and, to
some extent, to modulate the lesion itself in order to have
hypalgesia or analgesia without anesthesia. On the other
hand, MVD, which is not a neurolesive operation, consists
of the separation of the retrogasserian root away from the
impinging vessel using an interposed foreign body or by the
transposition of vessel without interposition of synthetic
material [50]. The operation is based on the assumption that
TN is caused by NVC. 
The average immediate postoperative pain relief and
long-term recurrence are the same for TPRT and MVD. For
both operations, the percentage of recurrence is different in
the various series. The different percentages of recurrence
after TPRT (from 6.7% in the paper of Schvarcz [43] to 50%
in the paper of Latchaw et al. [38]) depend on:
1. The different pre-determined end-points of operation:
analgesia or hypalgesia. In the paper by Latchaw et al.
[38], at 5 years relapses occurred in 26% of the patients
in which the operation produced analgesia or anesthesia,
in 54% of patients in which it produced hypalgesia, and
in 100% of patients in which no sensory deficits were
caused.
2. The technical differences. Recurrence (particularly early
relapses) can be due to an approximate technique.
Performed by a skilled operator, TPRT allows the precise
location of the cannula within the retrogasserian division
and the lesion can be accurately confined. TPRT is rela-
tively time consuming: it takes up to 2 hours and must be
performed according to the following operative steps [51]:
(a) Identification by fluoroscopy in oblique projection of
the sector of the oval foramen (the medial third for
trigeminal division I-II and the middle third for III):
this step takes only a few minutes;
(b) Localization of the trigeminal cistern (this structure
can be more or less deeply located depending on the
length of the mandibular branch);
(c) Electrophysiological identification of the target (this
step is time consuming because at any attempt the
operator must wait for the patient to awake prior to
stimulation and for subsequent sedation prior to
moving the electrode);
(d) Progressive thermolesion and verification of the
obtained pin prick hypalgesia-analgesia.
The different percentages of recurrence after MVD (from
6% in the study of Klun [52] and of Sindou and Mertens [53]
to 47% in the study of Burchiel et al. [40]), apart from the
operator’s different technical experience, can reflect the dif-
ferent criteria in the selection of the patients or, merely, the
casual inclusion of patients with or without true NVC.
If one considers the different surgical risks (operative
death of MVD is 20-times greater than that of TPRT), 21%
of recurrence after MVD can be regarded as a disappointing
outcome in comparison with 24.4% after TPRT. The recur-
rence rate after MVD is so high that terms such as “failed
microvascular decompression” [54–56] and “failed posteri-
or fossa exploration” [57] were coined. In order to define
indications for MVD, we must explain if MVD is the etio-
logic and definitive treatment for TN and if it really does not
provoke facial sensory impairments nor postoperative
dysesthesia.
Is MVD the etiologic treatment for TN?
MVD is the etiologic treatment when NVC occurs.
Nevertheless, whereas most TN patients have NVC, some
do not [24, 58]. Moreover, NVC is a common finding in
asymptomatic patients [59], in some TN patients it is con-
tralateral to the pain [60] and, finally, many nerve roots are
physiologically in contact with arteries and veins in the skull
[61]. In order to make clear the concept of NVC and to study
its pathogenetic role, the papers of Hardy and Rhoton [59]
and Haines et al. [58] are quoted. Hardy and Rhoton bilater-
ally examined the trigeminal roots in 25 corpses of subjects
who never had TN. They found that in 30 of 50 nerves, there
was contact between an artery and the trigeminal root: 26 of
the contacts were with the superior cerebellar artery (SCA)
and 4 were with the antero-inferior cerebellar artery
(AICA). Quoting this study, Adams and Chir [61] observed
that arterial loop and neurovascular contact were present at
least on one side in every examined subject and that as “each
patient had a vessel in contact with one or other trigeminal
nerve … one can conclude that it is unusual not to find some
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vascular contact in asymptomatic patient at or near the root
entry zone”. In other words, arterial loop and neurovascular
contact seem to be physiological. Haines et al. [58] exam-
ined 80 corpses: 40 without and 40 with a history of TN.
These authors found, respectively, neurovascular contact
and compression in 48% and 10% of the subjects without
TN and in 28% and 80% of the subjects with TN. They con-
cluded that arterial loop and neurovascular contact are com-
mon but cause TN only if the vessel exerts a “significant
compression” on the root. At surgical exploration the root is
“distorted” and shows a groove where the artery pulses.
Piatt and Wilkins [62, 63] verified clinically these anatomi-
cal findings and correlated the surgical outcome with the
nerve-vascular relation type. They found that MVD cured
TN in 83%, 62% and 42% of the cases if, respectively, dis-
tortion of the root by an artery, contact of the root with an
artery without distortion or contact-distortion of the root
with a vein were present. Hence, the type of neurovascular
relationship is crucial and arterial loop and neurovascular
contact are to be distinguished by the compression and dis-
tortion of the root (or NVC). The latter has pathogenetic rel-
evance whereas the simple arterial loop and neurovascular
contact are unimportant anatomical abnormalities. Of the
same opinion were Niwa et al. [64] who pointed out the dif-
ference between contact which is asymptomatic and com-
pression which is symptomatic. Moreover, as NVC is not
present in every TN patient, it is not the only cause of
“essential” TN but one of the possible causes [65]. As
demyelination is constantly present in every patient, natural
aging can figure among the other causes of neuralgia [66].
Is MVD the definitive treatment for TN?
MVD is the definitive treatment for TN if there is NVC and
there is not a severe neuropathic lesion of trigeminal root.
Recurrence can be ascribed to the postoperative fibrotic
adhesions formed around the nerve [56], to the intrinsic
lesion [67] and especially to the absence of NVC.
Does MVD not provoke facial sensory impairments?
Facial sensory impairment occurred in an average of 8.9%
of all patients treated with MVD and in 20% in the series of
Burchiel et al. [40]. Searching for corneal sensitivity after
neurosurgical interventions on the trigeminal nerve,
Ackermann-Kaorner and Draeger [68] found that MVD may
lead to a severe decrease of corneal sensitivity. In terms of
complications concerning sensory loss of cornea, TPRT was
the less risky treatment, followed by RGI, MVD and retro-
gasserian rhizotomy according to Frazier [69]. Hence, it
seems a hazard to guarantee patients that MVD does not
cause sensory deficits: nevertheless, severe dysesthesia is an
unusual complication.
Selection of patients
It is current opinion that TPRT has an established place
because of its safety, particularly in elderly patients, and that
MVD has an appeal in younger patients [70–76] because of
its non-destructive nature. However, there are presently no
clear guidelines for the choice of percutaneous or open oper-
ation. In order to establish such guidelines, it is crucial to
preoperatively distinguish NVC from the innocent arterial
loop and neurovascular contact and to recognize the type
(reversible or irreversible) of intrinsic nerve lesion. The pre-
operative distinction between NVC and arterial loop was
difficult in the past because angiography and computed
tomography (CT) showed the arterial loop and neurovascu-
lar contact but not the size of compression. At operation,
Tew et al. [60] found a “significant” impingement in less
than half of 50 patients in whom preoperative study showed
arterial loop and neurovascular contact. Fortunately, today
magnetic resonance imaging (MRI) is a reliable technique to
study neurovascular interaction at the trigeminal root entry
zone [64, 77–93] and it must be performed in every TN
patient candidate to MVD. Meaney et al. [86], sustaining
that MRI is “an extremely sensitive and specific method for
demonstrating vascular compression in TN”, concluded that
“open surgical procedures can be recommended with confi-
dence”.
Allowing the choice of MVD only at the presence of a
demonstrated nerve compression, we can expect that the
accuracy in the identification of NVC with MRI will reduce
the percentage of postoperative failures and recurrence.
Today, it is possible to demonstrate NVC but unfortunately
there is no available method to preoperatively recognize the
reversibility or irreversibility of the intrinsic nerve lesion in
TN and consequently to identify the patients who surely will
improve after MVD. This uncertain diagnosis remains the
most frequent cause of failure, because if there is irre-
versible nerve damage, decompression does not ameliorate
the symptoms and neurolesion is the only available treat-
ment.
MVD is a successful operation when the indication is
correct. Probably, many failures and relapses are the conse-
quence of an inadequate selection of patients, after opera-
tions performed on the presumption that MVD is in any case
the ideal cure for TN. With the availability of MRI, it can be
stated that MVD is not an alternative of percutaneous tech-
niques, favorable if the patients can tolerate a major opera-
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tion: it has firm indications (Fig. 1) and the diatribe between
the supporters of percutaneous techniques and MVD can be
concluded with the following statements: (1) percutaneous
techniques are indicated for patients without demonstrated
NVC (including  patients with TN-MS) and in those with
NVC if MVD is contraindicated by a concomitant illness or
is refused by the informed patient, and (2) MVD is indicat-
ed in patients with ascertained NVC, without severe trigem-
inal neuropathy and in good health who, informed of the
surgical risk, favor this operation desiring no sensory deficit
and hoping to be among the more than 80% subjects who
have no postoperative sensory deficits.
Fig. 1 Choice of open or percutaneous surgical procedures for trigeminal neuralgia. NVC, neurovascular conflict; MVD, microvascular
decompression
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